A. Gonçalves, R. Sabatier, C. , E. Gilabert, M. Provansal et al., Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives, Bull Cancer, vol.100, issue.5, pp.453-64, 2013.

J. Moretta, P. Berthet, V. Bonadona, O. Caron, O. Cohen-haguenauer et al., Recommandations françaises du Groupe Génétique et Cancer pour l'analyse en panel de gènes dans les prédispositions héréditaires au cancer du sein ou de l'ovaire, Bull Cancer, vol.105, issue.10, pp.907-924, 2018.

, Ministère de la Santé et des Solidarités. Plan national maladies rares, 2005.

S. Boisson-dupuis, N. Ramirez-alejo, Z. Li, P. E. Rao, G. Kerner et al., Tuberculosis and impaired IL-23-dependent IFN-? immunity in humans homozygous for a common TYK2 missense variant, Sci Immunol. 21 déc, vol.3, issue.30, p.8714, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-02070591

R. Jacob, A. Tremblay, V. Drapeau, V. Provencher, and L. Pérusse, Susceptibilité à l'obésité : rôle des déterminants génétiques des comportements alimentaires, Can J Diet Pract Res. déc, vol.78, issue.4, pp.197-203, 2017.

J. R. Pon and M. A. Marra, Driver and Passenger Mutations in Cancer, Annu Rev Pathol Mech Dis. 24 janv, vol.10, issue.1, pp.25-50, 2015.

A. A. Alizadeh, V. Aranda, A. Bardelli, C. Blanpain, C. Bock et al., Toward understanding and exploiting tumor heterogeneity, Nat Med. août, vol.21, issue.8, pp.846-53, 2015.

, Dépistage du cancer du sein en France: Identification des femmes à haut risque et modalités de dépistage, Laboratoires et consultations. 10. HAS, vol.34, 2014.

S. Goodwin, J. D. Mcpherson, and W. R. Mccombie, Coming of age: ten years of next-generation sequencing technologies, Nat Rev Genet. juin, vol.17, issue.6, pp.333-51, 2016.

, Selecting the best NGS enrichment assay for your needs

. Illumina, An Introduction to Next-Generation Sequencing Technology

, « Homogénéisation de l'interprétation de variants de séquence, p.22

S. E. Plon, D. M. Eccles, D. Easton, W. D. Foulkes, M. Genuardi et al., Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results, Hum Mutat, vol.29, issue.11, pp.1282-91, 2008.

G. Defossez, L. Guyader-peyrou, S. Uhry, Z. Grosclaude, P. Colonna et al., Estimations nationales de l'incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Synthèse, vol.20, 2019.

M. Espié, A. Hamy, S. Eskenazy, C. Cuvier, and S. Giacchetti, Épidémiologie du cancer du sein. EMC -Gynécologie, vol.7, pp.1-17, 2012.

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell. mars, vol.144, issue.5, pp.646-74, 2011.

, Recommandations INCa -femmes porteuses d'une mutation de BRCA1 ou BRCA2

P. Pourquier, La réparation de l'ADN, cible potentielle d'un développement thérapeutique en cancérologie, Bull Cancer, vol.21, 2006.

, Etude des predispositions génétiques aux cancers sein/ovaire

O. Cohen-haguenauer, Prédisposition héréditaire au cancer du sein (2): Risques et prise en charge. médecine/sciences, avr, vol.35, issue.4, pp.332-377, 2019.

B. G. Haffty, Q. Yang, M. Reiss, T. Kearney, S. A. Higgins et al., Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer, J Clin Oncol. 20 déc, vol.24, issue.36, pp.5652-5659, 2006.

R. Bhargava, J. Striebel, S. Beriwal, J. C. Flickinger, A. Onisko et al., Morphologic Features and Proliferation Indices of Breast Carcinoma Molecular Classes Using Immunohistochemical Surrogate Markers, vol.12, 2009.

P. Naïbo, Cancer du sein triple négatif: histoire naturelle et étude des facteurs génétiques impliqués. Sciences du Vivant, 2018.

F. Danlos, M. Papo, and J. Micol, L'hématopoïèse clonale : un concept émergent à la croisée des spécialités, Rev Médecine Interne, vol.40, issue.10, pp.684-92, 2019.

F. J. Couch, S. N. Hart, P. Sharma, A. E. Toland, X. Wang et al., Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer, J Clin Oncol. 1 févr, vol.33, issue.4, pp.304-315, 2015.

H. Shimelis, H. Laduca, C. Hu, S. N. Hart, N. J. Thomas et al., Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing, JNCI J Natl Cancer Inst. 1 août, vol.110, issue.8, pp.855-62, 2018.

S. S. Buys, J. F. Sandbach, A. Gammon, G. Patel, J. Kidd et al., A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes: Panel Testing in Women With Breast Ca, Cancer. 15 mai, vol.123, issue.10, pp.1721-1751, 2017.

Z. Baretta, S. Mocellin, E. Goldin, O. I. Olopade, and D. Huo, Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis. Medicine (Baltimore), vol.95, p.4975, 2016.

Y. A. Wang, J. Jian, C. Hung, H. Peng, C. Yang et al., Germline breast cancer susceptibility gene mutations and breast cancer outcomes, Disponible sur, vol.18, 2018.

E. R. Copson, T. C. Maishman, W. J. Tapper, R. I. Cutress, S. Greville-heygate et al., Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study, Lancet Oncol. févr, vol.19, issue.2, pp.169-80, 2018.

P. Desai and G. J. Roboz, Clonal Hematopoiesis and therapy related MDS/AML, Best Pract Res Clin Haematol. mars, vol.32, issue.1, pp.13-23, 2019.

M. L. Slovak, V. Bedell, D. Lew, K. S. Albain, G. K. Ellis et al., Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012), Breast Cancer Res Treat. janv, vol.119, issue.2, pp.391-399, 2010.

S. Jaiswal, P. Fontanillas, J. Flannick, A. Manning, P. V. Grauman et al., Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes, N Engl J Med. 25 déc, vol.371, issue.26, pp.2488-98, 2014.

S. J. Park, R. Bejar, C. Engel, K. Rhiem, E. Hahnen et al., Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triplenegative breast cancer without family cancer history, 37. on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer, vol.83, pp.105-117, 2018.

S. Yadav, R. Ladkany, D. Yadav, O. Alhalabi, S. Khaddam et al., Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer, Clin Breast Cancer. oct, vol.18, issue.5, pp.1229-1264, 2018.